Trial | NCT02832089  Report issue

Official Title

Oral Carvedilol in Escalating Doses in the Acute Treatment of Atrial Fibrillation

  • Phase

    Phase 3

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Intervention/Treatment

    carvedilol ...

  • Study Participants

    30
Oral carvedilol administered in escalating doses in patients with atrial fibrillation among patients with AF with fast ventricular rate.
Patients with AF with FVR of any etiology were evaluated and given escalating doses of oral carvedilol in doses - 3.125mg OD, then 3.125 bid, then 6.25mg bid, then 12.5mg bid. The ECG was recorded regularly and analysed for rate reduction or control.
Study Started
Dec 31
2000
Primary Completion
Mar 31
2002
Study Completion
Mar 31
2002
Last Update
Jul 14
2016
Estimate

Drug oral carvedilol

oral carvedilol in escalating doses for reducing ventricular rate in AF patients

  • Other names: oral carvedilol in esclating doses

active arm Experimental

single arm study with one group given oral carvedilol.

Criteria 

Inclusion Criteria:

AF with fast ventricular rate

Exclusion Criteria:

-
No Results Posted